Once millions used it to find out about their family histories - this week it was almost delisted. What went wrong?

Andre Fernandez, Jim Frankola and Mark Jensen will join the company's CEO Anne Wojcicki on the board. 23andMe appointed three ...

According to Anne Wojcicki, CEO and Co-Founder of 23andMe ... with ‘genetics as the foundation’. Through Lemonaid, which operates as both a telehealth and a prescription pharmacy service ...

In September, the company parted ways with all board members with the exception of CEO Anne Wojcicki ... activists from the Electronic Frontier Foundation (EFF) have summarized in a blog post ...

"We're really at a point in time where I'm ready to explode," 23andMe CEO Anne Wojcicki told CNBC in 2021. "There's huge opportunities in therapeutics and huge opportunities in our consumer business." ...

It's at risk of being delisted from the Nasdaq. Every independent board member has signed leaving only the founder CEO and Anne Wojcicki last year, the company had a massive data breach that ...

American businesswoman Anne Wojcicki is the co-founder and CEO of genetic testing company 23andMe. She became a billionaire after the company went public in 2021 but since then, the company’s ...

With 23andme in a desperate situation and eyeing a potential sale, Medical Device Network examines what is set to happen to ...

Anne Wojcicki, Eren Bali, Jay Desai, Nish Bhat, Matt Mochary, and others. To learn more, visit ambiencehealthcare.com. KLAS is a research and insights firm on a global mission to improve ...

2006: 23andMe is founded in Silicon Valley 23andMe CEO Anne Wojcicki co-founded the company ... The director of cybersecurity at Electronic Frontier Foundation, a nonprofit focused on digital ...

2006: 23andMe is founded in Silicon Valley 23andMe CEO Anne Wojcicki co-founded the company in 2006 with biologist Linda Avey and Paul Cusenza, who previously worked at the now-defunct Perlegen ...